Peter Kell's phase-one findings also tackle enforceability, vulnerability support, and First Nations engagement — with stakeholder feedback open until 8 May 2026.
Accelerating medical cost inflation, strained combined ratios, and rising protection gap demands urgent joint action from governments, regulators and insurers.
Moody's stable outlook for China's P&C insurance sector reflects an industry where underwriting discipline is gaining ground, amid growing asset risk and accelerating market concentration.
The development highlights ongoing regulatory efforts to address cost pressures and execution challenges in India’s rapidly growing private health insurance market.
The new rules will trim IP rider prices by about 30% on average, but insurers still face mounting pressure to manage claims and risk‑pool shifts in a high‑inflation environment.
